Emory University Hospital

When Neuralstem (NYSE: CUR) announced that it had been successful in reversing the progression of ALS in 39-year-old Ted Harada, many wondered if researchers were finally on the cusp of a cure. Gizmodo chronicled the impressive story of the man, who showed signs of recovery last year after...